Maureen Krajeski, PHARMD | |
34 Haverhill St, Pharmacy Dept, Lawrence, MA 01841-2884 | |
(978) 852-6016 | |
Not Available |
Full Name | Maureen Krajeski |
---|---|
Gender | Female |
Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
Location | 34 Haverhill St, Lawrence, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326455346 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | PH26183 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Maureen Krajeski, PHARMD 34 Haverhill St, Pharmacy Dept, Lawrence, MA 01841-2884 Ph: (978) 852-6016 | Maureen Krajeski, PHARMD 34 Haverhill St, Pharmacy Dept, Lawrence, MA 01841-2884 Ph: (978) 852-6016 |
News Archive
Data analyzed by scientists at the National Institute of Environmental Health Sciences suggest that breastfeeding can reduce the risk of death for infants in their first year of life. Looking at infants between 28 days and one year of age, researchers concluded that promoting breastfeeding can potentially prevent up to 720 postneonatal deaths in the U.S. each year.
In recent years, hospitals have reported dramatic increases in the number of cases of the highly contagious, difficult-to-treat, and often deadly antibiotic-resistant bacteria carbapenem-resistant Enterobacteriaceae (CRE). Now, investigators at Beth Israel Deaconess Medical Center have developed a promising method of identifying new antimicrobials that target these organisms. The research is published in April issue of the journal ASSAY and Drug Development Technologies.
The American Association for the Study of Liver Diseases Foundation, the largest private supporter of liver disease research and training in the United States, today announced its investment of $3.42 million in Research and Career Development Awards granted to 29 researchers and clinicians to conduct innovative liver disease research and seek advanced hepatology training.
Janssen Pharmaceuticals, Inc., and its development partner, Bayer HealthCare, today announced results from PMSS (Post-Marketing Safety Surveillance) and XANTUS (XARELTO for Prevention of Stroke in Patients with Atrial Fibrillation), their landmark real-world studies evaluating the safety of XARELTO in people with non-valvular atrial fibrillation (NVAF).
› Verified 6 days ago
Rithy Meas, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 135 Broadway, Lawrence, MA 01840 Phone: 978-725-3221 | |
Dr. Houry Daghlian, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 73 Winthrop Ave, Lawrence, MA 01843 Phone: 978-687-0445 | |
Dr. Alicia Mam Dacunha, PHARMD, AE-C, BCACP Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 73d Winthrop Ave, Lawrence, MA 01843 Phone: 978-689-6790 | |
Dr. Olga Cristina Tejada, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 73d Winthrop Ave, Pharmacy, Lawrence, MA 01843 Phone: 978-689-6790 | |
Mrs. Rosaly V Ulrich, PHARM.D-RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 34 Haverhill St, Lawrence, MA 01841 Phone: 978-857-3858 | |
Dr. Shardul S Patel, PHARM.D., R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 34 Haverhill St, Lawrence, MA 01841 Phone: 978-806-0024 Fax: 978-494-4141 | |
Mr. Robert M Gladstone, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 150 Park St, Lawrence, MA 01841 Phone: 978-686-4453 |